Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00007033 · ClinicalTrials.gov registry record · NA
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT00007033 is a NA study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 25 participants.
The verdict
NCT00007033, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease.
Interventions
- DRUG magnesium sulfate
- DRUG magnesium gluconate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2000-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00007033
The ClinicalTrials.gov registry entry for NCT00007033 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which magnesium sulfate is the first listed.
NCT00007033 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00007033 about?
NCT00007033 is a clinical study titled "Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease". OBJECTIVES: I. Determine the role of magnesium deficiency in the pathogenesis of decreased serum vitamin D and reduced bone density in children with chronic cholestatic liver disease.
What is the current status of trial NCT00007033?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2000-10.
What interventions are being tested in trial NCT00007033?
The interventions under investigation include: magnesium sulfate (DRUG), magnesium gluconate (DRUG).
Who is sponsoring clinical trial NCT00007033?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.